Initiation of Antiresorptive Drug Treatment during Endocrine Therapy for Breast Cancer—A Retrospective Cohort Study of 161,492 Patients in Germany

Endocrine therapy (ET), which significantly reduces breast cancer (BC) recurrence and mortality rates, is the primary systemic therapy for hormone receptor positive BC. However, in addition to frequently reported TAM- and AI-related side effects, such as hot flashes, arthralgias, and myalgias, treat...

Full description

Bibliographic Details

Main Authors:	Gremke, Niklas, Griewing, Sebastian, Kadys, Arturas, Kostev, Karel, Wagner, Uwe, Kalder, Matthias
Format:	Article
Language:	English
Published:	Philipps-Universität Marburg 2023
Subjects:	breast cancer denosumab tamoxifen antiresorptive therapy Germany Medizin aromatase inhibitors bisphosphonates endocrine therapy Medical sciences Medicine
Online Access:	PDF Full Text
Tags:	Add Tag No Tags, Be the first to tag this record!